Learn more about the effects of COVID-19 on medical surge capacity, the NDMS pilot program, and partnerships and accomplishments to date by registering for this NCDMPH webinar.
CDC’s next PHEP Connects webinar, “PHEP Connects Legal Preparedness Series, Part I: the Past, Present, and Future of Legal and Administrative Preparedness,” is scheduled for 1 p.m. EST on Wednesday, February 8. Presenters will provide an overview of legal and administrative preparedness principles for public health emergencies and explore the tools and training resources currently
Debunking misinformation is critical for establishing and increasing vaccine trust, confidence, and equity. This event, hosted by the Association of State and Territorial Health Officials (ASTHO), will highlight best practices for identifying and dispelling misinformation and discuss ways to assist groups most at risk of being exposed and influenced by misinformation through creative social media
The work of this committee includes assisting the Chair, Region 11 RHCC, in providing adequate medical evaluation and care planning during incidents that exceed the limits of the normal medical infrastructure within the community. Those with particular interest and/or expertise in pediatrics are encouraged to participate. This event is currently closed for registration.
The work of this committee includes the coordination of trainings for healthcare responders and supporting agencies in order to provide the required knowledge, skills, and abilities needed to prepare and respond to a disaster. This event is currently closed for registration.
The work of this committee includes the coordination and ability to conduct multijurisdictional, multidisciplinary exchange of public health and medical related information and situational awareness between the healthcare system and partners. This event is currently closed for registration.
Post-COVID conditions (PCC), also referred to as Long COVID or post-acute sequelae of SARS-CoV-2 infection (PASC), is an umbrella term for the wide range of health consequences that are present 4 or more weeks after SARS-CoV-2 infection. Most children infected with SARS-CoV-2 have asymptomatic infection or mild acute symptoms with low rates of hospitalization and
The Centers for Disease Control and Prevention (CDC) has detected an increase in extensively drug-resistant (XDR) Shigella infections (shigellosis) reported through national surveillance systems. XDR shigellosis is resistant to all generally recommended antibiotics in the United States, making it difficult to treat. XDR shigellosis is a serious public health threat: XDR Shigella bacteria have limited